German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform
Dortmund-based iDEL Therapeutics has secured €9 million in Seed financing to pioneer a novel cancer therapeutics platform. This funding, led by BiomedVC and supported by other venture capital firms, will fuel the development of treatments designed to deliver therapeutic agents directly into the cytosol of tumor cells. The company's innovative synthetic shuttle technology aims to overcome challenges in intracellular drug delivery, potentially unlocking new treatment avenues for a range of cancers and improving patient outcomes by enhancing target engagement and prolonging therapeutic effects. iDEL Therapeutics' platform utilizes a unique pan-cancer uptake mechanism that bypasses endosomal trapping, ensuring high drug exposure within cells and sustained retention within tumors. This technology is versatile, compatible with both large and small molecules, including advanced payloads like nanobodies against oncogenes. The company is focused on advancing its preclinical proof-of-concept data and lead candidates toward clinical trials, with an eye toward scalable value creation through strategic partnerships. This investment situates iDEL Therapeutics within a broader European landscape of significant funding in oncology research, where companies like T-CURX and FoRx Therapeutics have recently raised substantial capital for their distinct cancer treatment modalities. The sustained investment in diverse therapeutic strategies, including cell therapies, immunotherapies, and novel molecular targeting, underscores the region's commitment to advancing cancer care. Germany, in particular, shows continued activity in the biotech sector, with investors like BiomedVC actively backing promising ventures.
Curated and translated by Europe Digital for our multilingual European audience.
Source Information
European Alternatives You Might Like
Mangopay
Mangopay is a payment infrastructure provider specializing in payments for marketplaces and platforms. It offers virtual wallet technology for managing funds, enabling features such as split payments, multi-currency support, and KYC/AML compliance. Key functionalities include automated payouts, transaction monitoring, and customizable payment flows. This service is primarily aimed at businesses that manage marketplaces, crowdfunding platforms, and sharing economy models and require complex payment solutions. Mangopay distinguishes itself by offering a flexible and scalable payment solution specifically designed for platform-based business models, allowing them to control cash flows and streamline payment processes.
Scaleway
Scaleway is a European cloud computing provider offering a range of services, including servers, storage, and networking solutions. Key features include bare metal servers, virtual machines, object storage, and managed Kubernetes. It's suitable for developers, startups, and businesses seeking cloud infrastructure for web applications, data storage, and various other workloads. Scaleway distinguishes itself through competitive pricing and a focus on European data sovereignty, with data centers in France and the Netherlands.